Inhibrx Biosciences INBX
NASDAQ INBX
$90.61 -1.13 (-1.23%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibrx Biosciences (INBX) Common Stock Issued (2023 - 2026)

Updated

Inhibrx Biosciences (INBX) reported Common Stock Issued of $1.25 million for Q4 2025, up 256.3% from the prior quarter.

Analysis

Inhibrx Biosciences (INBX) Common Stock Issued (2023 - 2026) Analysis & Trends

For FY2025, Inhibrx Biosciences posted Common Stock Issued of $1.61 million, down 97.8% from FY2024.

  • By year, Common Stock Issued came in at $71.68 million in FY2024 (-64.6%) and $202.32 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Common Stock Issued since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 743.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 87.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Inhibrx Biosciences 1.45 Bn 882.42 Mn - 1.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Mar 31, 2026 471,000.00
Dec 31, 2025 1.25 Mn
Sep 30, 2025 352,000.00
Jun 30, 2024 32.95 Mn
Mar 31, 2024 38.73 Mn
Dec 31, 2023 1.09 Mn
Sep 30, 2023 200.02 Mn
API Access

Inhibrx Biosciences Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INBX&period=max&api_key=YOUR_API_KEY